Table 1. Clinical and demographic characteristics of patients with acute kidney injury (n = 90). Brasília, DF, Brazil, 2020/2021.
| Variables | n (%) | Mean (±SD) | Median (25–75) |
|---|---|---|---|
| Sex | |||
| Male | 50 (55.6) | – | – |
| Female | 40 (44.4) | – | – |
| Age (anos) | – | 62.54 (15.5) | 64.5 (50–74) |
| Weight (kg) | – | 70.83 (16.19) | 68 (61.75–79.5) |
| Height (cm) | – | 162.76 (10.48) | 161 (155.5–168) |
| BMI (kg/m 2 ) | – | 26.46 (4.7) | 26.49 (23.12–29.81) |
| COVID | 21 (23.3) | – | – |
| Outcome | |||
| Mortality | 13 (14.4) | – | – |
| Discharge | 55 (61.1) | – | – |
| Referral to another unit | 22 (24.4) | – | – |
| Post-discharge deaths | 22 (28.6) | – | – |
| Ethnicity | |||
| Nothing to declare | 1 (1.1) | – | – |
| White | 14 (15.6) | – | – |
| Black | 2 (2.2) | – | – |
| Brown | 73 (81.1) | – | – |
| Clinical data of patients pre-admission to the medical clinic | |||
| Admitted to another unit | 81 (90.0) | – | – |
| Received blood transfusion | 17 (21.0) | – | – |
| Used antibiotics | 42 (51.9) | – | – |
| Use of NSAIDs | 27 (33.3) | – | – |
| Use of ACE inhibitors | 24 (29.6) | – | – |
| Mobility during hospitalization | |||
| Bedridden | 29 (32.2) | – | – |
| Wandering | 61 (67.8) | – | – |
| Level of consciousness 1 | |||
| Awareness | 73 (81.1) | – | – |
| Torporous | 5 (5.6) | – | – |
| Comatose | 4 (4.4) | – | – |
| Confused | 7 (7.8) | – | – |
| Comorbidities | – | ||
| Diabetes mellitus | 48 (53.3) | – | – |
| Systemic arterial hypertension | 65 (72.2) | – | – |
| Respiratory diseases | 25 (27.8) | – | – |
| Heart disease | 50 (55.6) | – | – |
| Hepatopathy | 10 (11.1) | – | – |
| Neoplasms | 9 (10.0) | – | – |
| Smoking | 25 (27.8) | – | – |
| Alcoholism | 22 (24.4) | – | – |
| Blood transfusion | 8 (8.9) | – | – |
| Axillary temperature (°C) | – | 36.37 (0.7) | 36.3 (36.03–36.6) |
| Oxygen therapy | |||
| Nasal cannula | 13 (14.4) | – | – |
| Oxygen mask | 9 (10.0) | – | – |
| Non-invasive ventilation | 2 (2.2) | – | – |
| Tracheostomy (macronebulization) | 12 (13.3) | – | – |
| KDIGO | |||
| 1 | 31 (34.4) | – | – |
| 2 | 27 (30.0) | – | – |
| 3 | 32 (35.6) | – | – |
| Kidney recovery | |||
| 10 days | 14 (34.1) | – | – |
| 30 days | 23 (46.9) | – | – |
| Medical discharge | 23 (45.1) | – | – |
| 6 months | 6 (75.0) | – | |
| HD dependency after discharge | 12 (14.6) | – | – |
N – Absolute frequency; SD – Standard deviation; BMI – Body Mass Index; NSAID – Non-steroidal anti-inflammatory drugs; ACEI – Angiotensin-converting enzyme inhibitor; KDIGO – Kidney Disease: Improving Global Outcomes; °C – Degrees Celsius; HD – hemodialysis; 1 – Data missing in 1 patient.